Zhang K, et al.Mol Ther. 2015 Jun;23(6):1077-1091. doi: 10.1038/mt.2015.46. Epub 2015 Mar 20.Mol Ther. 2015.PMID: 25794051.Free PMC article.
.
. Shen KN, et al.Circulation. 2021 Sep 10. doi: 10.1161/CIRCULATIONAHA.121.055953. Online ahead of print.Circulation. 2021.PMID: 34503349. Inker LA, et al.N Engl J Med. 2021 Sep 23. doi: 10.1056/NEJMoa2102953. Online ahead of print.N Engl J Med. 2021.PMID: 34554658. Kanji JN, et al.Vaccine. 2021 Sep 15;39(39):5563-5570. doi: 10.1016/j.vaccine.2021.08.022. Epub 2021 Aug 11.Vaccine. 2021.PMID: 34454782.Free PMC article.Clinical Trial.
.
Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
